Klee Justin B.

Klee Justin B. is listed in filings as Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 9, 2026, including sale activity. Recent filings connect the profile to Amylyx Pharmaceuticals, Inc. (AMLX). The current snapshot covers public activity from Oct 2, 2024 to Mar 9, 2026. Reported amounts are shown as $59.4K to $30.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.